# Open-Label Study Evaluating Synera® in the Treatment of Patients With Carpal Tunnel Syndrome

> **NCT00991068** · PHASE2 · COMPLETED · sponsor: **ZARS Pharma Inc.** · enrollment: 24 (actual)

## Conditions studied

- Carpal Tunnel Syndrome

## Interventions

- **DRUG:** Synera (lidocaine 70 mg and tetracaine 70 mg) topical patch

## Key facts

- **NCT ID:** NCT00991068
- **Lead sponsor:** ZARS Pharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2012-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00991068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00991068, "Open-Label Study Evaluating Synera® in the Treatment of Patients With Carpal Tunnel Syndrome". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00991068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*